Market Tracker

05/30 4:45pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

8.90
Delayed Data
As of May 27
 -0.07 / -0.78%
Today’s Change
4.15
Today|||52-Week Range
10.74
+4.09%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close8.97
Today’s open8.90
Day’s range8.79 - 9.09
Volume85,661
Average volume (3 months)119,807
Market cap$116.7M
Dividend yield--
Data as of 4:00pm ET, 05/27/2016

Growth & Valuation

Earnings growth (last year)-8.06%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book4.14

Competitors

 Today’s
change
Today’s
% change
DPRXDipexium Pharmaceuti...-0.07-0.62%
--Sun Biopharma Inc0.000.00%
PRQRProQR Therapeutics N...+0.30+6.59%
BDSIBioDelivery Sciences...+0.02+0.96%
Data as of 4:00pm ET, 05/27/2016

Financials

Next reporting dateJune 29, 2016
EPS forecast (this quarter)-$0.21
Annual revenue (last year)$0.00
Annual profit (last year)-$7.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, Jerusalem

Forecasts